BioInvent and Transgene to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses
- Tuesday, March 3, 2020, 7:10
- Business
- Add a comment
LUND, Sweden and STRASBOURG, France , March 3, 2020 /PRNewswire/ — BioInvent International AB (“BioInvent”) (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext…
About the Author
adminasapcorp has written 39023 stories on this site.